- MÜV Hollywood is the third MÜV dispensary in Broward County and the ninth to open in Florida since late June, highlighting the company’s continued expansion across the state.
- The dispensary is located on Taft Road, a busy thoroughfare, with an average daily traffic of over 16,000 cars.1
- Verano’s active operations span 13 states, including 110 dispensaries and 13 cultivation and processing facilities with over 1 million square feet of cultivation capacity
CHICAGO, Aug. 18, 2022 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a major multi-state cannabis company, today announced the opening of the MÜV Hollywood dispensary on Friday, August 19, 2022, the 56 of the societye Florida Dispensary and 110e at national scale. MÜV Hollywood, located at 6661 Taft Road, is open Monday through Saturday from 9 a.m. to 7 p.m. and Sunday from 11 a.m. to 5 p.m. local time.
MÜV Hollywood is conveniently located north of Taft Street in the Hollywood Festival Shopping Center, a community location with an abundance of staple stores and local restaurants. A few minutes to the east is the boardwalk, a tourist destination with a two-mile-wide stretch of boardwalk built to accommodate walkers, joggers, and cyclists that offers stunning views of the Atlantic Ocean.
“MÜV Hollywood is a dispensary we’ve been looking forward to opening for some time, given its proximity to two of the most densely populated counties in the state – Broward and Miami-Dade,” said John Tipton, president of Verano. “Our team is ready and excited to welcome the strong community of local medical patients to MÜV Hollywood, where they will experience our efficient pickup and express delivery options, high-quality products, and world-class care.”
As a demonstration of Verano’s commitment to providing a convenient and reliable experience for Florida patients, MÜV Dispensaries offers online menus to effortlessly browse their extensive selection of award-winning products, including the exclusive Verano Reserve line of flowers. of the society. The company also offers one-on-one virtual and in-store consultations at no cost to the patient and provides patient-centric concierge services by phone (833-880-5421), email, web chat and text to answer questions and requests. patients. . For added convenience and accessibility, patients can choose to pre-order at muvfl.com or through the MÜV mobile app available in Google Play and Apple App stores for express in-store pickup.
MÜV’s comprehensive product selection includes edibles, chocolates and lozenges, flowers, pre-rolls, a range of vape pens, concentrates, metered dose inhalers, topicals and oral sprays; as well as patented encapsulating formulations in its EnCaps™ capsules, tinctures, 72 hour transdermal patches and transdermal gels.
For more information about the MÜV Hollywood Medical Cannabis Dispensary, visit muvfl.com.
About Verano
Verano is a leading, vertically integrated, multi-state cannabis operator in the United States, dedicated to the continuous improvement of collective well-being by providing responsible access to regulated cannabis products. With a mission to meet vital health and wellness needs, Verano produces a full line of innovative, premium cannabis products sold under its trusted portfolio of consumer brands, including Verano.™Avexia™, Bis™, and MÜV™. Verano’s portfolio encompasses 14 US states, with active operations in 13, including 13 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds and operates dispensaries under retail brands such as Zen Leaf™ and MÜV™, providing a superior cannabis shopping experience in the medical and adult markets. Learn more at www.verano.com.
contacts:
Media
Verano
Grace Bondy
Manager, Communications
[email protected]
Investors
Verano
Julianna Paterra, CFA
Director, Investor Relations
[email protected]
Forward-looking statements
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements are not indicative of historical facts or information or of the current situation, but rather represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and beyond the Company’s control. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “does not expect”, “is planned”, “budget”, “future”, “planned”, “estimates”, “plans”, “projects”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or may contain statements that certain actions, events or results “could”, “could”, “would”, “could” or “will be taken”, “will continue”, “will occur” or “will be carried out”. Forward-looking statements involve and are subject to known and unknown assumptions and risks, uncertainties and other factors that may cause the Company’s actual events, results, performance or achievements to differ materially from the events, results, performance and future achievements. expressed or implied by the forward-looking statements herein, including, without limitation, the risk factors described in the company’s registration statement on Form 10, as amended, and the quarterly reports on the Form 10-Q filed with the United States Securities and Exchange Commission at www. sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements contained or referenced herein, except to the extent reasonably possible. . required under applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this notice regarding forward-looking information and statements.
1 Florida Department of Transportation
Comments are closed.